Lorenz Trümper

Universitätsmedizin Göttingen — Germany

Medicine · Health Sciences

79h-index38.5kcitations469works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(254), Chronic Lymphocytic Leukemia Research(102), Viral-associated cancers and disorders(54), CAR-T cell therapy research(48), Cancer Genomics and Diagnostics(45)

Publications418 total

156 | EXCELLENT OUTCOME WITH INTERIM PET ADAPTED TREATMENT REDUCTION IN ELDERLY DLBCL PTSWITH FAVOURABLE PROGNOSIS: RESULTS OF 288 PTS TREATED IN OPTIMAL > 60 OF THE DSHNHL/GLA
Hematological Oncology·2025Open Access
157 | PET GUIDED OMISSION OF RADIOTHERAPY IN ELDERLY DLBCL PTS WITH LESS FAVOURABLE PROGNOSIS IS SAFE: RESULTS OF 863 PATIENTS TREATED IN THE OPTIMAL > 60 TRIAL OF THE DSHNHL/GLA
Hematological Oncology·2025Open Access
Subtyping Burkitt Lymphoma by <scp>DNA</scp> Methylation
Genes Chromosomes and Cancer·2025· 6 citedOpen Access
<scp>WNT5a</scp> export onto extracellular vesicles studied at single‐molecule and single‐vesicle resolution
FEBS Journal·2025· 2 citedOpen Access
Age‐ and gender‐specific molecular characteristics of diffuse large B‐cell lymphoma: Results from clinical trials of the DSHNHL/GLA
HemaSphere·2025· 1 citedOpen Access
<scp>MicroRNA</scp> Expression in High‐Grade B‐Cell Lymphoma With 11q Aberration
Genes Chromosomes and Cancer·2025· 5 citedOpen Access
Abstract 6968: Extracellular vesicles as carriers of signaling factors in cancer
Cancer Research·2024Open Access
Ärztlich assistierte Selbsttötung
Die Onkologie·2023· 1 citedOpen Access
Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients over 60 years of age: a prospective phase II study
Haematologica·2023· 5 citedOpen Access
Clonal hematopoiesis with TET2 mutations spawning synchronous primary central nervous system lymphoma and myelodysplastic syndrome
Annals of Hematology·2023Open Access
ICGC ARGO precision medicine: genomic profiling-informed prediction of immunotherapy response in two patients with metastatic head and neck squamous cell carcinoma
The Lancet Oncology·2023· 2 cited
Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients
HemaSphere·2023· 7 citedOpen Access
Subgrouping of Burkitt lymphoma variants by DNA methylation is driven by an EBV‐associated epigenotype
Hematological Oncology·2023Open Access
Allogeneic transplantation in T‐cell lymphoma: Lessons from the AATT study
Hematological Oncology·2023Open Access
Data from Circulating Levels of TNF Receptor II Are Prognostic for Patients with Peripheral T-cell Non–Hodgkin Lymphoma
2023Open Access
Supplemental Table 1 from CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas
2023Open Access
Table S3 from MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma
2023Open Access
Supplemental information from CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas
2023Open Access
Supplementary Figure 1 from Circulating Levels of TNF Receptor II Are Prognostic for Patients with Peripheral T-cell Non–Hodgkin Lymphoma
2023Open Access
Supplemental Figures 1-5 from CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Michael Pfreundschuh(20), Wolfram Klapper(19), Markus Loeffler(18), Andreas Rosenwald(16), German Ott(15), Reiner Siebert(15), Michael Hummel(14), Peter Mӧller(13), Monika Szczepanowski(13), Martin‐Leo Hansmann(10), Ralf Küppers(10), Harald Stein(9), Markus Kreuz(9), Julia Richter(9), Norbert Schmitz(8), Dido Lenze(8), Birgit Burkhardt(8), Marita Ziepert(7), Swen Weßendorf(7), Peter Lichter(7)